We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Cells Derived from Pluripotent Stem Cells may Pose Challenges for Clinical Use

Cells Derived from Pluripotent Stem Cells may Pose Challenges for Clinical Use

Cells Derived from Pluripotent Stem Cells may Pose Challenges for Clinical Use

Cells Derived from Pluripotent Stem Cells may Pose Challenges for Clinical Use

Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Cells Derived from Pluripotent Stem Cells may Pose Challenges for Clinical Use"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

UCLA researchers have found that three types of cells derived from human embryonic stem (hES) cells and from induced pluripotent stem (iPS) cells are similar to each other, but they are far more developmentally immature than those same cell types taken directly from human tissue.

In fact, the progeny of these hES and iPS cells are much more similar to cells found within the first two months of fetal development than anything later, according to the scientists from UCLA’s Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research.

The findings could have implications both clinically, in terms of transplantation, and for disease modeling, said William Lowry, senior author of the study and an assistant professor of molecular, cell and developmental biology in the UCLA Division Life Sciences.

The two-year study was published Aug. 16 in the peer-reviewed journal Cell Research.

"Once we found that the hES cell– and the iPS cell–derived progeny were similar, we wanted to understand how similar the progeny were to the same cells taken directly from human tissue," Lowry said. "What we found, looking at gene expression, was that the cells we derived were similar to cells found in early fetal development and were functionally much more immature than cells taken from human tissue.

"This finding may lead to exciting new ways to study early human development, but it also may present a challenge for transplantation, because the cells you end up with are not something that's indicative of a cell you'd find in an adult or even in a newborn baby."

There might also be challenges in disease modeling, unless one is modeling diseases that occur within the first two months of fetal development, Lowry said.

Employing the most commonly used methods for deriving cells from both hES cells and iPS cells, Lowry and his team differentiated these stem cells into three types of cells: neural progenitor cells, which create neurons and glia; hepatocytes, the main tissue found in the liver; and fibroblasts, common to the skin.

They selected those cell types because they are easy to identify and are among the most commonly differentiated cells made from pluripotent stem cells. They also represent cell types found in the three germ layers - the endoderm, mesoderm and ectoderm - where the first cell-fate decisions are made, Lowry said.

The progeny of hES cells and iPS cells were compared to each other using their gene expression patterns, functionality and appearance. There was little or no difference between them, Lowry said. Then the work began to compare them to equivalent cell types found in humans.

"One important reason to do this is to ensure that the cells we are creating in the Petri dish and potentially using for transplantation are truly analogous to the cells originally found in humans," said Michaela Patterson, first author of the study and a UCLA graduate student researcher. "Ideally, they should be as similar as possible."

The team found that while the progeny were alike, they had striking differences from the same cells found in humans in terms of gene expression. A significant number of genes, about 100, were differentially expressed in the cell types made from hES and iPS cells, Lowry said.

About half of those differentially expressed genes are normally thought to be strictly expressed in hES and iPS cells, which have the potential to differentiate into any cell of the three germ layers. Those genes had not been turned off, even after the cells had differentiated into either neural progenitor cells, hepatocytes or fibroblasts, Patterson said.

"Previously, we assumed that all pluripotency genes get shut off right away, after the fetus begins developing," Patterson said. "We found that this is not the case, and in fact some of these genes remain expressed."

The differences in gene expression could be problematic, Lowry said, because some of these same differentially expressed genes in the progeny are genes that are expressed during cancer development. Also worrisome was their developmental immaturity - would they work correctly when transplanted into humans?

As part of their study, the team left the differentiating cells in culture about a month longer to see if they would mature further. They found that there was some modest but statistically significant maturation. However, genetic discrepancies remained.

These discrepancies could be critical, Patterson said, particularly in the hepatocytes. During fetal development, these cells express proteins that aid the metabolism of the fetus, a role they don't play later in adults.

"The roles these cells play in the fetus and the adult are inherently different," she said. "It may be that the progeny, if transplanted into a human, would mature to the same levels as those found in the adult liver. We don't know."

The team then compared the progeny to cells from humans that were closer to the progeny's developmental maturity and found that the two types of cells were indeed becoming more similar in gene expression and functionality, Lowry said.

The UCLA team is not the first to suggest that the progeny of human pluripotent stem cells reflect an early developmental immaturity. However, these data put a more precise window on their developmental age.

Going forward, Lowry and his team plan to study the 100 genes being differentially expressed in the progeny to see if manipulating some or all of them results in the maturation of the cells.

"These findings provide support for the idea that human pluripotent stem cells can serve as useful in vitro models of early human development but also raise important issues for disease modeling and the clinical applications of their derivatives," the study states.

The study was funded in part by a seed grant and training grants from the California Institute of Regenerative Medicine, the Basil O'Connor Starter Scholar Award and the Fuller Foundation.